MYCN and neuroblastoma: In childhood neuroblastoma, the most important feature appears to be amplification of the MYCN proto-oncogene, which occurs in ~25% of primary tumors and is considered a high-risk aggressive clinical marker correlated with advanced stage disease and treatment failure [5,6].